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Glutathione ([l.-gamma-glutatny~-~.-cysteinyll glycine) is present 
in almost all cells in high concentrations (I), and functions as an 
intracellular reductant. The hypothesis (23) that glutathione 
plays an important role in protectioc: ceils against damage by free 
radicals, reactive oxygen species and toxic compounds has been 
supported by numerous studies using an ischemic-reperfusion 
model of myocardial infarction (4-6). During myocardial isch- 
emia and reperfusion, both myocardial reduced ghttathione con- 
tent and reduced/oxidized glutathione ratios within ischemic 
tissues are reduced (7-Y). The extent of myocardial cell injury 
sustained during reperfusion is deperldent on the degree of 
myocardial reduced glutathione content (5). 
An ideal method of increasing intracellular reduced glutathi- 
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one IWCIS is to :trlministrr a derivative ol’ reduced glutathionc that 
is readily converted to reduced glutathione after membrane 
transport, as reduced glutathione is not effectively transported 
into cells. Glutathione ester derivatives, such as methyl ester (IO), 
ethyl ester (10-12) aud isopropyl ester (13,14), are effectively 
transported into a number of cells and are rapidly de-esterified by 
intracellular esterase. Another promising approach for increasing 
intracellular reduced glutathione levels is to supply a substrate of 
glutathione synthetase. It is known that the synthesis of gamma- 
glutamylcysteine from glutamate and cysteine by gamma- 
glutamylcysteine synthetase is a rate-limiting step in glutathionc 
biosynthesis. Recently, gamma-glutamylcysteine ethyl ester has 
been developed as a precursor of glutathione (15). This com- 
pound can penetrate into cells in its intact form and then be 
converted to glutatbione as a substrate by glutathionc synthetasc 
after de-esterilication (16). This compound effectively maintains 
mitochondrial reduced glutathione content and reduces rcperfu- 
sion arrhythmias in canine hearts (17). Our unpublished obser- 
vations suggest that this compound increases ~~~t~~lccll~tar rc- 
duced glutathionc contenl in human er,dotbelial cells and ral 
hepatocytes pretreated with buthionine sulfoximine, an inhibitor 
of gamma-glutamylcysteine synthetase, more efficiently than does 
a glutatbione ethyl or isopropyl ester derivative. The purpose of 
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T&k 1. La& of EpicMa Cyanosis and Akinesia in lschemic Region and Lethal Arrhythmia 
Lack of Initial 
Do@ Cyanosis and Venlriculdr Successful St!& 
Ciroup Enrolled Akin& Fibrillation Detibrillation Group 
Control lY 4 2 1 I4 
GCE-L 16 ? I 1 14 
WE-H 15 2 1 I I3 
______.-... -IIIIW-.- -.- 
AU data indicate numba of dogs. GCE-H and GCE-L = groups receiving, respectively, the high (I0 m&t) and the 
ijose of gamma-glutamyl~steine ethyl ester. 
4dUlt fll#k Or fUlWlC mW~~rCi &j&S 
SO) wA2 i~~~~i~l~y ~~~cst~e~i~c~ with intravc- 
arhitdl stKiiucn (30 mgjkg body weight), and theln 
with a cuffed cndotrachcal tube and artificially 
ventilated. VenMory wriahlcs were adjusted on the basis of 
arterial blood gas mcasurcmcnts lo maintain a normal pH and 
adequate oxygen&m. Blood prcssurc was measured with ti 
catheter inserted into the left carotid artery. The heart late wils 
recorded from the blood pressure signal. The left jugular vein 
was used for drug administration. After a left thoracotomy was 
performed at the level of the tifth intercostal sp~e. the heart 
was suspended in u ~ri~rdi~{l cradle. A cathctcr was also 
in>scrted through the Icft atrial ~p~nd~~~e into the left atrium 
to serve as a conduit for the adnrinistratioa of colored micro- 
spheres. An occlusive snare was rthen p&cd around the Ieft 
jntcrior descending c~~r~~rn~~~~ ;~~opy distal to its first m;$r 
diagonal branch. Coronary occlusion was maintained for 
Fo min and followed by 5 h of reperfusion. ~em~y~amic 
NM&S were obtained IMbrc and 90 min after coronary 
X&S~OW and iit I, 3 and 5 h after rcperfusion. Jugular venous 
>lur;d samples wtx(: collected in hepurinized syringes at the 
:nd of the exgcrimcnt for measurement of plasma Credtine 
rinase activity. Cnatine kinase activity was measured by a 
Mtdard ctraphotometric method. 
The experimental animals were excluded according to the 
Wwing criteria, as previously described (18): 1) failure to 
nanifest epicardial cyanosis and akinesia within the left ante- 
ior descending coronary artery distribution after coronary 
%clusion; 2) intractable ventricular fibrillatian requiring more 
ban two attempts at defibrillation with low energy direct 
urrcnt (20-J) pulses applied directly to the surface of the 
!cart. Dogs were randomized by the envelope method for 
reatment with gamma-glutamylcysteine ethyl ester or no 
pecific treatment. Gamma-glutamylcysteine ethyl ester (3 [low 
hl or 10 [high dose\ mglkg, intravenously in normal saline 
ulution) was administered by bolus injection immediately 
efore coronary reperfusion. The pharmacokinetics of this 
urnpound in plasma after bolus injection has two phases: me 
the ~rcatcd g~ups. WC cxamirtcd three additiomd dogs as 
control dogs. Finally, 5 of 19 dogs assigned to the control group 
imd 4 of 3i dogs assigned to the trcetmrnt groups wcrc cxciuludcd, 
and data oI1 the%2 ik99dS were plot C~~~CCt~~~ 
was ~r~~)r~iC~ in accordance with gMidc~i~cs for treatment of 
experimental animals in 0saka Universily Seb~~l of Medicine. 
regular vein wkile the ~IlnM~~~~ed l ft a~~teri~r ~~~sce~~~~~ 
coronary artery ws perfused with autologous blood. The dogs 
were then killed. The hearts were removed and divided into six 
transverse slices of ~~ppr~)xio~~tely eq thicknesses. After 
c solution. the area 
of necrosis was ~orrna~i~ed to ii risk 20 ze for each heart. In 
our prelimio study, addition of gammt~-~lutan?ylcystcine ethyl
ester (up to gmul/liter) did not a&ct the area of necrosis in 
ischcmic my~~i~r~~ill~~ ass~s~d by triphenyltetrazolium chloride 
over control in 10 gmol/litcr and 92 of: 
oIlliter, n = 3, elreh). 
QW. Blood 
ftow measurements were made with 11.9 + LO-pm colored 
microspheres (Triton Technology, Inc.). The reference with- 
drawal method was used in this study (18). Injection of -5 
million microspheres labeled with either red, blar*k or brown 
dye into the left atrium was followed !+ a IO-ml saline flush. 
The reference blood was withdrawn at a constant rate 
(10 mllmin) from the carotid artery starting 10 s before the 
injection and continuing until 50 s after the injection. Myocar- 
dial blood flow was measured before and 45 min after pro- 
longed occlusion, and then 30 min after reperfusion. Risk 
region and infarct size were assessed at the conclusion of the 
experiment. Transmural siabs were cut from the ischemic and 
nonischemic regions of the midventricular slices. All reagents 
used for the processing of blood and tissue samples to quantify 
the colored microspheres were obtained from Triton Technol- 
ogy, Inc. The regional myocardial blood flow was measured by 
using subendocardial and s&epicardial samples of each slab 
(genere 1 to 2 g), and the results were expressed as mVmin per 
g. Data were excluded from the group comparison of infarct size 
for 3 min. The solutions were t 
-88°C unti; assuyed. Analysts wcrc performed 
one reductase and reduced n~cotinan~~de-adenine dinuc~eot~de 
phosphate. The rate of 5-thio-2-nitrobenzois acid for~nat~on was 
nm. Because rcduczd glutathione reacts rapid!y 
ne to form a conjugate, the supernddnt solu- 
tions of the tissue honloge~~ates were pretreated this agent 
before ~,~‘-~it~l~~~is ~~-l~it~ol~c~~~~)~c acid) was d for the 
measurement of oxidizeu glutathionc. Sixty minutes late<, the 
dcrivcd samples were assayed using the 5,5’-dithiobls (2- 
nitrobenzoic acid)-glutathione reductase reqcling assay. 
rv¶sasWX? 9 ~~~ta~~~~ne~~~~a~e~ enzyme 
activity. Myocardial tissue samples (0.1 to 0.2 g) wele homog- 
enized in 100 vol of 0.05 ol/litcr ~otassiun~ p~~osphate buffer 
(pH 7.0). The tissue homo were then centrifuged at 
2,000 6 for 15 min. ‘Che tant solutions were also 
centrifuged at 105,UOO~ br 1 h. Finally, the supernatants wcrc 
stored at --8WC una!l ;~ssdyed. 
~lutat~ione peroxrdase activity analysis was performed by 
using a conrinuous monitorhg of oxidized glutathione foraa- 
tion, as previously described (22). Bricfy, the supernatant 
enzyme sample was pretreated with glutathione reductase 
(0.24 U/ml) and reduced +$tathione (I mmollliter) for 10 min 
at 37°C. Reduced nicotinamide adenine dinucleotide phos- 
phate (0.15 mmol/liter) was then added and the hydrogen 
peroxide-independent consumption of reduced nicotinamide- 
adenine dinucleotide phosphate was monitored for 3 min at 
340 nm. The overall reaction was initiated by adding hydrogen 
peroxide (0.15 mmol/liter). A unit of gltitathiorre p roxidase 
activity was defined as the amount of enzvme that catalyzed the 
reduction of 1 nmol of reduced nicotinamide-adenine d u- 
cleotide phosphatelmin. 
Glutathione reductase activity was also measured by con- 
tinuous monitoring ofreduced nicotinamideadenine di mcleo- 
tide phosphate consumption, aspreviously described (22). 
After pretreatment of the supernatant enzyme sample with 
reduced nica,tinamidc-ad~nine ~~~c~~~~t~~~ ~~~~~~~~~ 
.1 mmol/iiter), the oxidized glut t&one-independent con_ 
sumplion of reduced nicotinamidc-adeninr dinucleotide phos_ 
pbatc was monitored at ) lam hr 3 min at WC. ‘I’hc w_!~~~l 
reaction wa? ~n~t~atc~ by 
liter). A unit of glutat~~ Heductasc activity was defined as 
unl of cnzymc that cataiy he reduction of 1 nmd 
cd nicotjnamidc-adeninc 
E&C%. All values are expressed as mean 
lferences in infarcr size, myocardial 
emodyaamie vakiab8es. &rial changes in the mean artc- 
rial blood pressure, heart rate and the heart rare-systo 
pressure (rate-pressure) product are shown in Tab! 
data presented include those obtained bcforc sustained left 
anterior drsccnding coronary artery occlusion, at the end 01 
the YO-min occlusion and after 1, 3 and 5 h of rcpcrtuaion. .% 
moderate but not significant dccrcasc in heart rate was noted 
ogs treated with the low dose of gamma 
I ester afFcr reperfusion. Thcrc was no di 
eahcs bcrwccn treated and control groups at 
The heart rute and mean arterial blood pressure were similar 
among the groups. The rate-prcssurc product. an estimate of 
myocardial oxygen consumption, did not differ significantly 
between the treated ,nd the control groups and did not 
fluctuate from baseline throughout the experiment. Therefore, 
hemodynamic variables during sustained occlusion and reper- 
fusion wcrc cornparablc in the hvo groups. Ncithcr the heart rate 
nor the mean ,utcnial blood prcssurc changed at 5 and 30 min 
after the bolus infusion of gamma-glutamylcysteinc ethyl cstcr in 
experiments using additional groups of dogs (data not shown). 
farct size. The data on infarct size from three to four dogs 
in each group having subendocdrdial blood flows >(I. 1 f mb’min 
per g during sustained occlusion were excluded from analysis. 
The final number of dogs analyzed in each group wilS 10. 
Infarct size, expressed as Fhc pcrccnt of thC ~~~t~~~i~ ilk% id 
risk, was si@icantIy lower in the groups treated with gamma- 
glutamylcysteine ethyl cstcr (low dose [ 3 mg/kg] 26.4 2 WIT 
p < 0.05; I@$ dose [IO mcs/kg] 10.0 -+ 3.4%; p C 0.05) than in 
the control group (40.6 t 4.8%) (Fig. 1). The anatomic arca at 
risk, defined as a percent of the left ventricle, did not differ 
significantly between the treated and the control groups (&!, 
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Table 2. Hemodynamic Data in the Final Study Groups 
Before 
Sustained 90 min of 
GfOUD Baseline Occlusion Occlusion 
Reperfusion 
Ih 3h 5h 
CQntrQl 
HR 
MAP 
RPP 
GCE-L 
HR 
MAP 
RPP 
GCE-H 
HR 
MAP 
RPP 
156 t 8 
10526 
192 2 I2 
150 c 6 
loOc6 
175 r II 
i43 2 4 
IO5 * H 
184ZZ# 
155 rt 18 
9827 
192 ? 15 
150 2 6 
97 26 
174 % 15 
143 c 4 
108 * 5 
I&Id H 
148 ?I 7 147 I! 13 
98 z 10 109-c 11 
18Oz20 183~23 
146?Y3 136 2 6 
91 2: 7 9628 
165 4 15 160+ 18 
14625 140 ‘c 5 
9928 11026 
177 + 14 182 c I5 
145 + 16 
93 2 9 
150 I 25 
130 t 9 
97 r 9 
150 f 25 
13h i 17 
9029 
166t35 
126 t 17 
W?9 
148 r 17 
Wucs arc cxprcsscd as mean value ‘c SEM. Each pup contained 10 dogs. HR = heart rate (bcatslmin): 
arterial hkwd prwure (mmH@; RPP = wtc-prcssurc product (~iirn~f~rnill X IRO): other abhrcvinlions as ia ‘l”uhlc 1. 
I). When plnsms creatine kinase activity witi examined in 
Inr venous blood samples at the nd of the experiment, it 
was noted that there was a significant reduction among the 
treated in a dose-dependent manner (control 7,640 + 
1,650 m 3 mg/kg 4,510 + 980 mIU/ml; 10 mg!kg 3,800 C
620 mtU/ml, p < 0.05 versus control, respective!y). 
onal my~a~ial blond flow. Regional myocardial 
blood flow was measured before occlusion (baseline) and 
45 min after occlusion ofthe left anterior descending coronary 
cc 1. Bar graphs comparing the myocardiail area at risk exprescd 
percent of Ihc left ventricle (glp ne9) and the infarct ilren 
expressed as a percent of the area t nel) for the control 
ated with the low dose (3 
, GCE-M) of gamma.glura 
All groups underwent WI mia of rgional ischcmia followed by 5 b of 
rcp&sian. Values arc expressed as mean value 2 SBM (n = 10 for 
each). *p < 0,5; versus the value in the control group as assessed by 
analysis of variance, 
40 
30 
Aree et Risk/Left Ventricle 
Infarcted Area/Area at Risk 
ocardial glut&lone redox state. Figure 3 shows the 
myocardial glutathione content within nonischemic and isch- 
emit regions at 5 h after reperfusion. Although no difference 
was noted in myocardial reduced glutathione content within 
nonischemic regions among the three groups, the myocardial 
reduced glutathione content of the ischemic region was signif- 
icantly different. Inthe control group, the reduced glutathione 
content was markedly reduced in the ischemic region relative 
to that in the nonischemic region, an area that was preserved 
in the treated groups. However, there was no difference in 
myocardial oxidized glutathione content of the nonischemic or 
ischemic region among the three grout. 
Control GCE-I. GCE-H Myocardial glutarhione-related enzyme activity within the 
artery (Table 3). In the hi 
regional my~ardia~ bloo 
reperfusion. I  all grou 
not change significant 
ose-tr~atcd and cant 
was aPs0 exa~~ncd 3 
with regard to regional n~y~~trdia 
endocardial or subepicardial ische 
~~lns~~~ or after 3 
artery-perfused r gion during the sustained ischemic period is 
shown in Figure 2. An inverse linear relation between the 
normalized infarct size and the regional subendo~ardial blood 
flow during ischemia was noted in all groups. However, the
regression li e in each treated group was significantly different 
(p < 0.01, ~C~VA) from that in the contra! group (i.e., the 
absolute infarct size at any given regional myocardial b ood 
flow was reduced significantly in each treated group). These 
findings indicate that differences in regional myocardial blood 
flow cannot fully explain the infarct-limiting effects of gamma- 
glutamylcysteine ethyl ester treatment. 
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nonischemic and ischemic ~~~y~c~~r~9iMl~~ is shown ian Figarrc 4. 
There was no ~it~~~e~ce in myoca all ~9~tat9~~~~~e peroxidasc 
activity ~e~wee~~ the ~~~~i~scllemic d isclmemic regions either 
or among the three groups. In contrast, 
ione reductase activity was significantly dif- 
ferent in the ischemic region. Glutathione reductase activity 
ow3r (p < 0.05) in the ischemic than in the 
ium in the control 
ic myocardium oft 
a dose-dependent fashion. There was no difference in gluta- 
Gone reductase activity within the nonischemic rnyocardium 
among the three groups. 
sion. Gamma-glutamylcysteine ethyl ester can penetrate into 
cells in its intact form and tllen be converted to reduced 
F&W 2. Linear regression a alysis of infarct size expressed as a
percent ofthe area t risk versus regional myocardial blood flow 
to the left ventricular. subendocardium ring sustained occlusion 
in the control group and in dogs treated with gamma- 
@utamylqsteine thyl ester. An inverse linear elation behueen 
the normalized infarct size and the regional myocardial blood 
flow during ischemia was noted. However, the absolute infarct 
size at any given regional myocardial blood flow was significantly 
lower in each treated group (p < 0.01) than that in the control 
group, as assessed by analysis of covariance. Abbreviations as in 
Figure 1. 
~9~u~~t~~io~ie by ~9~~~t9l~~~le syntherase, leading to an increase in 
i~~t~ac~91~9a~ reduced ~9~tat~~o~~e concentrations (16). 
amined the ~~~~rct-9imiti~ig effects of this agent whe 
immediate9y before reperfusion in a canine coronary occlu- 
sion-reperfusion model of myocardial infarction. Treatment 
with gamma-glutamylcysteine ethyl ester ( 
venously) resulted in a significant dose-de 
infarct size. However, no difierences were 
namic variables or regional myocardial 
periods of ischemia or after reperfusion between the con:ro9 
and treated groups. A decrease in reduced glutathione content 
within ischemic myocardium was ohscaved in the control group 
but this decrease was significantly suppressed by the treatment 
in a dose-dependent fashion. There wcrc no differences ill 
oxidized glutathione content between the nonischemk and 
ischemic myoca;,dium among the three groups for each region. 
Although glutatlaione peroxidase activity was not di%erent in 
the ischemic myocardium among the three groups, treatment 
66 - - - GCE.L 
_._._. GCE.)j 
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Nonlfdwmio lrchrmic 
3, Myocardial content of rcduccd ylutathionc (GSH, uppr 
I) and oxidized glutathionc (OS%, r panel) in nonischcmic 
and isshemic regions of control dogs and dogs treated with &iNlltllW 
~ut~rn~l~teine ethyl ester. Values are expressed as muan valve t 
SEM (n = 10 for each), *p C 0.05 versus the value in the control group 
as assessed by analysis of variance. Other ahbrcviations as in Figure 1. 
with high dose gamma-gluta!nylcysteine ethyl ester significantly 
preserved glutathione reductase activity in ischemic myocardium 
compared with the level in the control group. These results 
indicate that gamma~glutamyl~teine ethyl ester si~ifi~ntiy 
attenuates myoeardial ischemic and re~r~sioa injury. 
compounds such as reduced tathionc have been shown to 
sed was particularly high (6.5 
ischemia foliowed by repeffusion in both rat (4) and 
(6) models. Forman ct al. (23) showed in a canine model 
that treatment with N-acetylcysteinc, a precursor of reduced 
utathione having superoxide dismutase activity, reduced 
yoeardial stunning but did not limit infarct size. However, the 
investigators noted no difference in total glutathione content 
ichcmic myocardium between the control and 
In our study, the use of gamma-glutamylcysteine ethyl ester, 
another precursor of reduced ghrtathione, significantly reduced 
i@rct size in association with the preservation of myocardial 
reduced glutatllione content vithin ischemic regions in a 
dose-dependent manner. The administration of gamma- 
ghttamylqsteine ethyl ester has previously been shown not only to 
mitigate isehemia-reperbtsion-induced liver injury in rats (24) but 
SACS Vol. L4, Na. 5 
Novcmher I. 1994:1_%1-7 
GPX 
Nanischamie Ischamic 
~~~~~ 4. CJlutathione pc c panel) and ~~~t~tlli~)nc 
rtlductilse (GR. IOWW noirtschcniic iMId iSCh- 
emit myocardium in c trented with gamma- 
rnyl~st~i~e ethyl ester. Values are expressed as mean value f 
(o = 141 for GKh). *p < 0.05 VCrSUS VdMC i?l thC COlltPd gKNl 
ilSSCSSCd hy imalySis of variance. ~t~~cr ahhrcviations as in Figure 1. 
also to redu~ my~ardia~ reperfusion arrh~bmias in dogs (I?). It 
should be noted that whereas the ~tody of Golan et al. (23) 
i~~~.~~~ ~~~~~Ct Sk 83 
of reperfusion, our st evaluated these variables 5 
reperfusion. As previo al. (BP), there 
was no difference in oxidized ~~tatbio~e come een noniseh- 
hemic rny~~~i~rn in each group of our study, 
ne content in i~he~~ic my~ardi~m is 
eatment. i  is well onion that 
cardial oxidiied glutat e content increases during oxidative 
stress (7,s). We (25) have pre~ously reported thatsublethal 
ischemia, caused by brief repeated regional ischemia-reperfusion 
episodes, increases oxidized glutathione content within isehemic 
my~ardium. In the present s udy, excess oxidized glutathione 
within ischemic myocardium was either efficiently excreted 5 h 
after reperk&on or was reduced to reduced gl~~~thio~e by 
glutathione reductase, thus leading to a normalization of myoear- 
dia glutathione content w;thin isehemic regions. 
Wons. The precise .nechanism by which gamma- 
glutam~l~teine ethyl ester educed infarct size remains to be 
elucidated. The similar levels of reduced glutathione content in 
nonisehemic myoeardium in all three groups are evidence that 
gamma-glutamylcysteine ethyl ester m;ay cause an increased syn- 
thesis of reduced glutathione only in such situations a ischemia 
when myocardial reduced glutathione Icontent is decreased. Sev- 
eral studies (26,27) using antioxidant enzymes such as superoxide 
dismutase with or without catalase have shown reduction of 
infarct size when these agents are given before or at he time of 
reperfusion. However, the ability of these agents oreduce infarct 
size has remained uncertain (28,29); in some studies (30-32), they 
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